| AKBA Stock Yearly Return 2023 Table | ||||||||||||||||||||||||||||||
AKBA average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare AKBA average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| AKBA Share Performance |
| AKBA Stock Yearly Return 2023 Chart | |||
Also see: • AKBA YTD return • AKBA average annual return 10 years | |||
| About Akebia Therapeutics Inc |
| Akebia Therapeutics is a biopharmaceutical company. Co.'s portfolio includes a late-stage product candidate and a commercial product: Vadadustat, which is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor designed to mimic the physiologic effect of altitude on oxygen availability; and Auryxia® (ferric citrate), which is approved and marketed in the U.S. for two indications which are the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis or the Hyperphosphatemia Indication, and the treatment of iron deficiency anemia (IDA) in adult patients with CKD not on dialysis or the IDA Indication. The AKBA stock yearly return is shown above.
The yearly return on the AKBA stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2023 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the AKBA annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| AKBA Current Stock Quote |
 Free AKBA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Akebia Therapeutics (AKBA) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
AKRO Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.
Video: Don't Forget Dividends in Average Annual Return!